Medication Safety

Product Risk Assessment Tools

15 March 2016Product risk assessment tools to support NHS organisations to identify risk resultant from medicinal product presentation.

Safety considerations when using Vitamin D

7 September 2022Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm

Using intravenous paracetamol preparations safely in paediatrics

21 September 2022Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.

Giving intermittent intravenous infusions by gravity in adults

12 July 2023Infusion by gravity is not the preferred method of administration, but may be necessary in some circumstances. Ensure a risk assessment is undertaken.

Safe management of therapeutic drug monitoring

2 October 2024Organisations must ensure safe management systems are in place to support the management of drugs requiring therapeutic drug monitoring.

Implementing self-administration of medicines

25 January 2023Individuals receiving healthcare should be supported to continue to self-administer existing/new medications unless there are reasons why they are unable to

Purchasing for safety

19 June 2024Using principles of purchasing for safety when making purchasing decisions supports the safe clinical use of medicines and can minimise inadvertent harm

Managing the risks associated with patients prescribed clozapine

28 June 2024Healthcare professionals in non-specialist services managing patients prescribed clozapine should implement safe practice principles to prevent potential harms.

MSATS - Safe Use of DOACs

30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.